Synopsis
0
USDMF
0
JDMF
0
KDMF
0
VMF
0
FDA Orange Book
0
Canada
0
Australia
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
CEP/COS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] EU WC
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]NDC API
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
INTERMEDIATE SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Europe
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]South Africa
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
73
PharmaCompass offers a list of Tenoxicam API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Tenoxicam manufacturer or Tenoxicam supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Tenoxicam manufacturer or Tenoxicam supplier.
PharmaCompass also assists you with knowing the Tenoxicam API Price utilized in the formulation of products. Tenoxicam API Price is not always fixed or binding as the Tenoxicam Price is obtained through a variety of data sources. The Tenoxicam Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Reutenox manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Reutenox, including repackagers and relabelers. The FDA regulates Reutenox manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Reutenox API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Reutenox manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Reutenox supplier is an individual or a company that provides Reutenox active pharmaceutical ingredient (API) or Reutenox finished formulations upon request. The Reutenox suppliers may include Reutenox API manufacturers, exporters, distributors and traders.
click here to find a list of Reutenox suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Reutenox CEP of the European Pharmacopoeia monograph is often referred to as a Reutenox Certificate of Suitability (COS). The purpose of a Reutenox CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Reutenox EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Reutenox to their clients by showing that a Reutenox CEP has been issued for it. The manufacturer submits a Reutenox CEP (COS) as part of the market authorization procedure, and it takes on the role of a Reutenox CEP holder for the record. Additionally, the data presented in the Reutenox CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Reutenox DMF.
A Reutenox CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Reutenox CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Reutenox suppliers with CEP (COS) on PharmaCompass.
A Reutenox written confirmation (Reutenox WC) is an official document issued by a regulatory agency to a Reutenox manufacturer, verifying that the manufacturing facility of a Reutenox active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Reutenox APIs or Reutenox finished pharmaceutical products to another nation, regulatory agencies frequently require a Reutenox WC (written confirmation) as part of the regulatory process.
click here to find a list of Reutenox suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Reutenox as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Reutenox API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Reutenox as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Reutenox and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Reutenox NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Reutenox suppliers with NDC on PharmaCompass.
Reutenox Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Reutenox GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Reutenox GMP manufacturer or Reutenox GMP API supplier for your needs.
A Reutenox CoA (Certificate of Analysis) is a formal document that attests to Reutenox's compliance with Reutenox specifications and serves as a tool for batch-level quality control.
Reutenox CoA mostly includes findings from lab analyses of a specific batch. For each Reutenox CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Reutenox may be tested according to a variety of international standards, such as European Pharmacopoeia (Reutenox EP), Reutenox JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Reutenox USP).
